Trading / Browse Companies / Rani Therapeutics Stock

Rani Therapeutics Stock

ranitherapeutics.comHealthcareFounded: 2012Funding to Date: $116.33MM

Rani Therapeutics is the developer of a platform for the oral delivery of biologic drugs.

Learn more about Rani Therapeutics IPO
Register for Details

For more details on financing and valuation for Rani Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Rani Therapeutics.

Register Today

Rani Therapeutics investors also invested in these private companies

GV
Bossa Ventures
Cathay Venture
GeneScience Pharmaceuticals
Shire

Team

Management Team

Svai Sanford
Chief Financial Officer
Talat Imran
Founder & Chief Executive Officer
Mir Hashim Ph.D
Chief Scientific Officer & Board Member

Board Members

Andrew Farquharson
InCube Ventures
Blake Byers Ph.D
GV

Other companies like Rani Therapeutics in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
OURA
Sector
Healthcare
 
 
Headspace
Sector
Healthcare
Last Round Est. Valuation
$317.32MM
NowRx
Sector
Healthcare
Last Round Est. Valuation
$334.19MM
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
GoForward
Sector
Healthcare
Last Round Est. Valuation
$1.59B
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
VillageMD
Sector
Healthcare
 
 

Trending Companies

Frequently Asked Questions